chartexchange

Cannabix Technologies Evaluating Expansion into Breath-Based Health and Biomarker Market with Proprietary BCU “VOC” Platform

GlobeNewswire Inc. | Oct 28, 2026 8:40 AM EDT

VANCOUVER, British Columbia, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”), a developer of marijuana and alcohol breath testing technologies, announces that it is evaluating its Breath Collection Unit (BCU) technology, for strategic expansion into the rapidly advancing breath biomarker research and diagnostics sector. The Company has developed a version of its BCU that can be target volatile organic compound (VOC) in breath samples applicable for health, biomarker, and environmental testing markets.

Read original article